This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medicalscience advances, too many clinics still rely on cumbersome paperwork. Its simple: Digital patient intake forms. What is Digital Patient Intake? Whats the solution to such an age-old problem?
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. MSLs are key purveyors of scientific truth and viewed highly by HCPs/KOLs, and they are driven by their passion to help patients.
In the healthcare Operations field, achieving the best possible patient outcomes is paramount. This means ensuring patients not only understand their diagnosis but are also empowered to participate actively in their treatment plan. It utilizes computer-generated simulations to create realistic and interactive environments.
“NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medicalscience,” said Rob McKinney, Director, NEJM Group Licensing. NEJM is recognized as the world’s leading medical journal and website.
A series of studies and surveys have documented the fact that substantial numbers of physicians, nurses, and allied health professionals are active on or prefer social media for professional purposes and to connect directly with peers. A majority of HCPs want to receive relevant information on their own times and terms.
The main source of new and up-to-date information on medical research, clinical trials, treatment recommendations, and developments in medicalscience is medical journals. Making wise medical decisions and giving patients the best treatment possible depend on this.
In this era of grab-and-go learning, continuing medical education (CME) is being transformed by digital and AI technology, which tailors learning to meet individual HCP needs. This approach enhances patient outcomes and care by delivering education at the most receptive moments for healthcare professionals. Reference: 1.
Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. Asking strategic questions leads to a better understanding of medical practices and habits.
All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. are still done in an open fashion.
When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.
The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.
To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources. The rest of the patients had partial responses. with ten patients to try to duplicate the results.
More than ever, physician time is at a premium. Heavy patient loads, paperwork, research, presentations at medical meetings, and department/academic obligations make it tough to keep up with the literature, new therapies, and understanding of how community level and peers manage their patients.
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.
Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This offers new opportunities to engage with stakeholders beyond just physicians. In 2023, we will see MA engage both patients and payers more than in previous years.
contact information, medical specialties, accepted insurances, business hours, location, patient testimonials, and more) directly on the SERP. MedicalSpecialty Any specific branch of medicalscience or practice, including clinical specialties about organ systems and their respective diseases and allied health specialties.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medicalscience liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients. Get stakeholder buy in on the “why”.
With this comes new hope for previously underserved patient populations. But educating the world of physicians about these new medicines and collaborating with healthcare professionals on trials and other important initiatives is critical to their commercial success. Expanding horizons.
They have to meet with doctors, nurses, and healthcare administrators to whom they will have to present products, conduct demonstrations, and discuss patient needs and how offering meets them. Medical Education Specialist: Create CME/CE-accredited training on medical products for physicians.
1 Particularly, CAR-T cell therapy, which uses a patient’s T-cells to fight cancer by altering them so they can find and destroy cancer cells, has emerged as a valuable option for many patients. 2 With this new indication, more patients will be able to access this innovative treatment.
Career success in MedTech is not just about climbing the corporate ladder; it’s about relentlessly advocating for patients, embracing change, and, above all, never giving up. I am a person who has devoted his life to medical technology. We need to bring innovative new therapies to the market and the patients.
The Great Resignation, and other factors, are changing the makeup of every group within pharma marketing — manufacturers and marketers, agencies and partners, patients and caregivers, HCPs, and staff. We’re seeing brands increase budgets for Medical Affairs,” says Stewart Young, SVP, Strategic Planning, Intouch Proto.
Manufacturing woes have affected both cell and gene-modified cell therapies in oncology recently, disadvantaging patients with multiple myeloma (MM) and melanoma. DELTA-1 is a Phase II single-arm trial in metastatic melanoma, evaluating the efficacy of ITIL-168 in patients who have progressed on previous therapy.
1 EHRs have become the primary means for registering and seeing patients, making and documenting diagnoses, prescribing treatments, and implementing follow up, all in the pursuit of improving outcomes (both clinical and economic) and the user experience in healthcare. First, finding patients missing a specific immunization.
Hait , Executive VP, Chief External Innovation and Chief Medical Officer, Johnson & Johnson , a renowned physician-scientist and Treasurer of the American Association for Cancer Research engaged in a thought-provoking discussion on the evolving landscape of cancer research and treatment.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content